21.02.2014
- Dublin, Ireland-based generic drugmaker Actavis is acquiring specialty pharmaceuticals company Forest Laboratories of New York in a cash and stock deal valued at about $25 billion...
15.01.2013
- Forest Laboratories posted an unexpectedly large loss in its fiscal third quarter as sales of its antidepressant Lexapro were buffeted by generic competition and sales of its...
